Exploring Alectinib and Irinotecan as potential human kallikrein-1 inhibitors: a drug repurposing approach for cancer and dermatological disorders

Talha Jawaid, Mehnaz Kamal, Lamya Ahmed Al-Keridis, Mohd Adnan, Iqbal Hussain, Saud O. Alshammari, Nawaf Alshammari, Naved Azum, Taj Mohammad

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Exploring Alectinib and Irinotecan as potential human kallikrein-1 inhibitors: a drug repurposing approach for cancer and dermatological disorders'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science